In older patients with atrial fibrillation, anticoagulation was associated with more major bleeding or death among cognitively impaired individuals but not among cognitively intact individuals. #geriatrics https://t.co/vMlSlBae7l
Prescribing cascades lead to inappropriate co-prescribing of cholinesterase inhibitors and anticholinergics in many nursing home residents with severe dementia. The reverse "deprescribing cascade" is not observed in real-world care. #geriatrics https://t.co/iisfquGT7g
Trying to envision a scenario in which I encourage a patient with mild Alzheimer's to take a drug that's given intravenously every 4 weeks, costs $56,000+ per year, sometimes causes cerebral edema and microbleeds, and we have no idea if it works.
Nope.
https://t.co/7APrYa1okd
Patients with HFpEF deal with polypharmacy and other vulnerabilities like frailty that could prompt consideration for deprescribing. Patients with HFpEF report willingness for deprescribing if prompted by their doctor. #geriatrics#AGS21
https://t.co/61Isv6boiC